Finance

Lists
Why is NSPR up 2.11%?
Dive Deeper
NSPR:NASDAQ
InspireMD Inc
$0.77
+2.11%
(+0.016) 1D
Sep 22, 12:11:48 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSPR...
Open
$0.75
High
$0.81
Low
$0.75
Mkt. cap
35.60M
Avg. vol.
84.01K
Volume
119.17K
52-wk high
$2.56
52-wk low
$0.63
EPS
-$0.65
Beta
0.83
Shares outstanding
46.49M
No. of employees
127
Open
$0.75
High
$0.81
Low
$0.75
Mkt. cap
35.60M
Avg. vol.
84.01K
Volume
119.17K
52-wk high
$2.56
52-wk low
$0.63
EPS
-$0.65
Beta
0.83
Shares outstanding
46.49M
No. of employees
127
News stories
From web sources and news partners
About InspireMD Inc
CEO-
Employees127
Founded2005
HeadquartersMiami, Florida, United States
SectorMedical device
Websiteinspiremd.com
Analyst ratings
Based on 3 analysts giving stock ratings to NSPR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NSPR in the last 3 months.
Highest
Current $0.77
$4.00 (+422.33%)
Average
$3.33 (+334.84%)
Lowest
$3.00 (+291.75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Buy
Reiterated
$4.00
+422.3%
09/22/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
$3.00
+291.7%
08/19/2026
Adam Maeder
Piper Sandler
Buy
Maintained
$3.00
+291.7%
07/31/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
$3.00
+291.7%
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.52M
3.15M
3.40M
1.77M
Cost of goods sold
1.66M
1.97M
2.71M
2.54M
Cost of revenue
1.66M
1.97M
2.71M
2.54M
Research and development expenses
3.64M
3.48M
4.76M
4.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.28M
9.79M
9.90M
9.38M
Operating expense
13.92M
13.26M
14.66M
13.67M
Total operating expenses
15.57M
15.23M
17.38M
16.22M
Operating income
-13.05M
-12.08M
-13.98M
-14.44M
Other non operating income
-
-
-
-
EBT including unusual items
-12.71M
-11.70M
-13.69M
-14.32M
EBT excluding unusual items
-12.71M
-11.70M
-13.69M
-14.32M
Income tax expense
-
63.00K
-
-
Effective tax rate
-
-0.54%
-
-
Other operating expenses
-
-
-
-
Net income
-12.71M
-11.76M
-13.69M
-14.32M
Net profit margin
-503.69%
-373.48%
-402.85%
-808.81%
Earnings per share
-0.17
-0.14
-0.16
-0.17
Interest and investment income
343.00K
386.00K
289.00K
121.00K
Interest expense
-
-
-
-
Net interest expenses
343.00K
386.00K
289.00K
121.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.92M
-11.94M
-13.83M
-14.29M
Gain or loss from assets sale
-15.00K
1.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps